D. Boral Capital Maintains Buy on Coya Therapeutics, Maintains $15 Price Target

Coya Therapeutics, Inc. -1.77%

Coya Therapeutics, Inc.

COYA

4.45

-1.77%

D. Boral Capital analyst Jason Kolbert maintains Coya Therapeutics (NASDAQ: COYA) with a Buy and maintains $15 price target.